Promising rectal cancer study

A scientist comments on the evolving treatment of rectal cancer in light of findings from a study that found the immunotherapy drug dostarlimab was especially effective in a phase II clinical trial of a dozen patients with a subtype of rectal cancer.

4 Ways to Sleep Easy in a Market Crash

It’s never easy to watch your life savings evaporate before your very eyes. Still, you can set yourself up to better allow you to sleep even as the market falls.